Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218838 · ClinicalTrials.gov registry record · NA
Comparison of CornerLoc SI Joint Stabilization and Steroid Injections for Sacroiliac Joint Dysfunction
A NA study, sponsored by CornerLoc.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04218838: Clinical Trial NA study, sponsored by CornerLoc.
NCT04218838 is a NA study that was terminated before completion, run by CornerLoc. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04218838, a NA study, was terminated before completion, sponsored by CornerLoc.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study has been designed to compare the safety and effectiveness of the CornerLoc™ SI Joint Stabilization System to intra-articular sacroiliac joint steroid injection in patients with refractory sacroiliac joint dysfunction.
Primary Outcome
The efficacy responder rate is defined as the percentage of subjects who experience at least a 50% improvement in overall pain, as measured by the Numeric Rating Scale (NRS) for Pain, from Baseline to the 6-Month Visit. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
Interventions
- DEVICE CornerLoc SI Joint Stabilization Procedure
- DRUG Intra-articular Sacroiliac Joint Steroid Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-08-13 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
Why NCT04218838 stopped before completion
NCT04218838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which CornerLoc SI Joint Stabilization Procedure is the first listed.
NCT04218838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04218838 about?
NCT04218838 is a clinical study titled "Comparison of CornerLoc SI Joint Stabilization and Steroid Injections for Sacroiliac Joint Dysfunction". This study has been designed to compare the safety and effectiveness of the CornerLoc™ SI Joint Stabilization System to intra-articular sacroiliac joint steroid injection in patients with refractory sacroiliac joint dysfunction.
What is the current status of trial NCT04218838?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-08-13. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04218838?
The interventions under investigation include: CornerLoc SI Joint Stabilization Procedure (DEVICE), Intra-articular Sacroiliac Joint Steroid Injection (DRUG).
Who is sponsoring clinical trial NCT04218838?
This trial is sponsored by CornerLoc, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04218838's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI